This statistic shows the total revenue of biotech company Amgen from 2004 to 2017. In 2004, Amgen's total revenue amounted to some 10.55 billion U.S. dollars. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California.
Total revenue of biotech company Amgen from 2004 to 2017 (in million U.S. dollars)
Exclusive Premium Statistic
This statistic shows the total revenue of biotech company Amgen from 2004 to 2017. In 2004, Amgen's total revenue amounted to some 10.55 billion U.S. dollars. Amgen is a U.S.-based multinational biopharmaceutical company, headquartered in Thousand Oaks, California.
Statista Accounts: Access All Statistics. Starting from $588 / Year
Statistics on "Amgen"
Statista for Your Company: The Research and Analysis Tool
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Amgen's product sales revenues within the U.S. and internationally 2006-2011
- Group holdings by Amgen
- Amgen - revenue from Enbrel worldwide by region 2011-2017
- Amgen Foundation: donated funds
- Amgen: ad spend in the U.S. 2012-2014
- Amgen - ad spend in the U.S. 2014, by medium
- Revenue of Rituxan in selected countries 2012
- Human Genome Sciences: revenue forecast 2011-2014
- Dendreon: revenue forecast 2011-2014
- Global biotechnology revenue by region 2012
- Projected 2019 revenue for top drugs approved U.S. 2014
- Services from pharma companies to manage disease or health issue 2013
- Impact of the U.S. biopharmaceutical industry on output 2014
- Preferred services from a pharmaceutical company 2013
- Genentech product sales
- Number of pharmaceutical venture financing deals 2007-2014
- Mexico: main pharmacies 2017, by size
- Consolidated intermediate consumption pharmaceutic sector, the Netherlands 2004-2014
- Top therapeutic categories worldwide 2018, by number of R&D products
- China: smart grid market value in the software and hardware segment 2010-2015